MAP3K13 anticorps (C-Term, Ser869)
Aperçu rapide pour MAP3K13 anticorps (C-Term, Ser869) (ABIN2306944)
Antigène
Voir toutes MAP3K13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term, Ser869
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- MAP3K13, CT (S869) (MAP3K13, LZK, Mitogen-activated protein kinase kinase kinase 13, Leucine zipper-bearing kinase, Mixed lineage kinase)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- MAP3K13 (LZK) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human LZK.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
Autre désignation
- MAP3K13
-
UniProt
- O43283
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Antigène
-